Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Glutamate-mediate Excitotoxicity in Invasion and Progression Processes of Glioblastoma Multiforme

NCT05775458 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT05775458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05775458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Glutamate-mediate Excitotoxicity in Invasion and Progression Processes of Glioblastoma Multiforme
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2020
Completion date
September 30, 2029
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, primary